rs149898884
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_153717.3(EVC):c.1500G>A(p.Met500Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000311 in 1,613,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_153717.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EVC | NM_153717.3 | c.1500G>A | p.Met500Ile | missense_variant | 11/21 | ENST00000264956.11 | NP_714928.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVC | ENST00000264956.11 | c.1500G>A | p.Met500Ile | missense_variant | 11/21 | 1 | NM_153717.3 | ENSP00000264956.6 | ||
EVC | ENST00000509451.1 | c.1500G>A | p.Met500Ile | missense_variant | 11/12 | 1 | ENSP00000426774.1 | |||
CRMP1 | ENST00000506216.5 | n.1648-7987C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00149 AC: 226AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000390 AC: 97AN: 248410Hom.: 0 AF XY: 0.000343 AC XY: 46AN XY: 134200
GnomAD4 exome AF: 0.000189 AC: 276AN: 1460876Hom.: 0 Cov.: 32 AF XY: 0.000173 AC XY: 126AN XY: 726548
GnomAD4 genome AF: 0.00148 AC: 226AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.00159 AC XY: 118AN XY: 74440
ClinVar
Submissions by phenotype
Ellis-van Creveld syndrome Pathogenic:2Uncertain:1Benign:1
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | - | - - |
Pathogenic, no assertion criteria provided | research | Dan Cohn Lab, University Of California Los Angeles | Jun 01, 2017 | - - |
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 17, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Apr 02, 2018 | - - |
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 04, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 13, 2024 | Variant summary: EVC c.1500G>A (p.Met500Ile) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00054 in 279744 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in EVC causing Ellis-van Creveld syndrome, however the data suggest that the variant could be a benign polymorphism. c.1500G>A has been reported in the literature in individuals affected with Ellis-van Creveld syndrome as a compound heterozygous genotype (e.g. Zhang_2018) or as an unreported polymorphism (e.g. Sund_2009). This report does not provide unequivocal conclusions about association of the variant with Ellis-van Creveld syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 19251731, 29068549). ClinVar contains an entry for this variant (Variation ID: 446659). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 23, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29068549) - |
EVC-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 28, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at